Target Name: ZNF71
NCBI ID: G58491
Review Report on ZNF71 Target / Biomarker Content of Review Report on ZNF71 Target / Biomarker
ZNF71
Other Name(s): zinc finger protein 71 | Endothelial zinc finger protein induced by tumor necrosis factor alpha | Zinc finger protein 71 | Endothelial zinc finger protein induced by tumor necrosis factor alpha (isoform 1) | Kruppel-related zinc finger protein | ZNF71_HUMAN | EZFIT | Zinc finger protein 71, transcript variant 1 | ZNF71 variant 1

ZNF71: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. One of the ZFPs, ZNF71, has been identified as a potential drug target and biomarker for various diseases. In this article, we will discuss the biology of ZNF71, its potential drug targets, and its potential as a biomarker for disease.

The ZNF71 Protein

ZNF71 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and muscle. It is a zinc finger protein that contains a unique zinc finger domain, which consists of a nucleotide-binding oligomerization domain (NBO), a conserved domain, and a C-terminal domain. The NBO domain is responsible for the protein's Zn2+-dependent stability, while the conserved domain is involved in the protein's stability and functions. The C-terminal domain is involved in the protein's interactions with other proteins and factors.

Functions and Interactions

ZNF71 plays a role in various cellular processes, including cell growth, differentiation, and survival. It is a key regulator of the apoptosis program, which is responsible for cell death in response to various stimuli, such as UV radiation, UV radiation, and programmed cell death (PDD). ZNF71 is also involved in the regulation of cell proliferation, and it has been shown to inhibit the growth of cancer cells.

In addition to its role in the apoptosis program, ZNF71 is involved in the regulation of cell adhesion and migration. It has been shown to play a role in the regulation of tight junction formation and the maintenance of cell-cell adhesion. shown to be involved in the regulation of cell migration, and it has been shown to play a role in the development of cancer.

Potential Drug Targets

ZNF71 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. ZNF71 has been shown to be involved in the regulation of cell cycle progression, and it is a key regulator of the apoptosis program. This makes it an attractive target for drugs that are designed to induce or inhibit apoptosis.

In addition to its role in the apoptosis program, ZNF71 is also involved in the regulation of cell adhesion and migration. This makes it an attractive target for drugs that are designed to modulate these processes. ZNF71 has also been shown to play a role in the regulation of cell migration, and it is a potential target for drugs that are designed to inhibit this process.

Potential Biomarkers

ZNF71 has been shown to have potential as a biomarker for various diseases. For example, ZNF71 has been shown to be involved in the regulation of apoptosis, and it is a potential target for drugs that are designed to induce or inhibit this process. has also been shown to be involved in the regulation of cell cycle progression, and it is a potential target for drugs that are designed to modulate this process.

In addition to its potential as a drug target, ZNF71 has also been shown to have potential as a biomarker for various diseases. For example, ZNF71 has been shown to be involved in the regulation of apoptosis, and it is a potential target for drugs that are designed to

Protein Name: Zinc Finger Protein 71

Functions: May be involved in transcriptional regulation

The "ZNF71 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF71 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841